Losartan therapy in patents with Marfan syndrome

Trial Profile

Losartan therapy in patents with Marfan syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2014

At a glance

  • Drugs Losartan (Primary)
  • Indications Aortic disorders
  • Focus Therapeutic Use
  • Acronyms COMPARE
  • Most Recent Events

    • 24 Oct 2013 New trial record
    • 02 Sep 2013 Primary endpoint 'Clinical-response-rate' has been met according to results published in the European Heart Journal.
    • 02 Sep 2013 Results published in the European Heart Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top